{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:45:05Z","timestamp":1783446305589,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":3374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.fertnstert.2012.10.048","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T13:13:27Z","timestamp":1354194807000},"page":"1146-1152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Biomarkers in uterine leiomyoma"],"prefix":"10.1016","volume":"99","author":[{"given":"Gary","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torie C.","family":"Plowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Catherino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Y.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2012.10.048_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/molehr\/gap050","article-title":"Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays","volume":"15","author":"Bowden","year":"2009","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10815-012-9784-0","article-title":"Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances","volume":"29","author":"Levy","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib3","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0030-1251477","article-title":"New directions in the epidemiology of uterine fibroids","volume":"28","author":"Laughlin","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib4","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/humrep\/deh407","article-title":"Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study","volume":"19","author":"Marino","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ogc.2005.12.004","article-title":"Epidemiology of myomas","volume":"33","author":"Payson","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ogc.2005.12.008","article-title":"Myomas and assisted reproductive technologies: when and how to act?","volume":"33","author":"Kolankaya","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib8","first-page":"225","article-title":"The impact of uterine leiomyomas on reproductive outcomes","volume":"62","author":"Cook","year":"2010","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0015-0282(99)00532-4","article-title":"Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases","volume":"73","author":"Soares","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0029-7844(94)00298-R","article-title":"Transabdominal sonohysterography, transvaginal sonography, and hysteroscopy in the evaluation of submucous myomas","volume":"85","author":"Cicinelli","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7863\/jum.2002.21.3.237","article-title":"The added value of transvaginal sonohysterography over transvaginal sonography alone in women with known or suspected leiomyoma","volume":"21","author":"Becker","year":"2002","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0015-0282(01)01900-8","article-title":"Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy","volume":"76","author":"Dueholm","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pcad.2012.05.001","article-title":"Methodological and analytic considerations for blood biomarkers","volume":"55","author":"Christenson","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib14","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/des234","article-title":"Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis","volume":"27","author":"Vodolazkaia","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib15","first-page":"35","article-title":"An In\u00a0Vitro Diagnostic Multivariate Index Assay (IVDMIA) for ovarian cancer: harvesting the power of multiple biomarkers","volume":"5","author":"Zhang","year":"2012","journal-title":"Rev Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2012.10.048_bib16","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/IGC.0b013e318251c97d","article-title":"Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers","volume":"22","author":"Bast","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jnci\/djp438","article-title":"Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study","volume":"102","author":"Anderson","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/er.2011-1040","article-title":"Molecular mechanisms of prolactin and its receptor","volume":"33","author":"Brooks","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib20","first-page":"8","article-title":"Management of uterine leiomyomata: what do we really know?","volume":"100","author":"Myers","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib21","first-page":"1411","article-title":"Serum protein and prolactin as diagnostic markers","volume":"30","author":"Baban","year":"2009","journal-title":"Saudi Med J"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1044-579X(03)00028-2","article-title":"Secretion of sHLA-G molecules in malignancies","volume":"13","author":"Rebmann","year":"2003","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.fertnstert.2007.06.073","article-title":"Human leukocyte antigen-G is expressed by the eutopic and ectopic endometrium of adenomyosis","volume":"90","author":"Wang","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib25","first-page":"91","article-title":"Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma","volume":"30","author":"Basta","year":"2009","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib26","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.2174\/138161212802002689","article-title":"The role of bevacizumab in advanced epithelial ovarian cancer","volume":"18","author":"Kroep","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib27","first-page":"CD007930","article-title":"Angiogenesis inhibitors for the treatment of ovarian cancer","author":"Gaitskell","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/cs1010691","article-title":"Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium","volume":"101","author":"Gentry","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0015-0282(99)00476-8","article-title":"Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy","volume":"73","author":"Agrawal","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0015-0282(16)58390-3","article-title":"Vascular endothelial growth factor expression in cycling human endometrium","volume":"66","author":"Torry","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib31","first-page":"317","article-title":"Serum vascular endothelial growth factor165 levels and uterine fibroid volume","volume":"84","author":"Chen","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1373\/clinchem.2004.032482","article-title":"Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin","volume":"50","author":"Meier","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib34","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","article-title":"The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans","volume":"87","author":"Gnanapavan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib35","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1745-7270.2007.00360.x","article-title":"Involvement of ghrelin-growth hormone secretagogue receptor system in pathoclinical profiles of digestive system cancer","volume":"39","author":"Wang","year":"2007","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib36","first-page":"517","article-title":"Further studies on leptin and leptin receptor expression in myometrium and uterine myomas","volume":"26","author":"Markowska","year":"2005","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000334106","article-title":"Obestatin: an interesting but controversial gut hormone","volume":"59","author":"Lacquaniti","year":"2011","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.20925","article-title":"Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms","volume":"211","author":"Camina","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1677\/ERC-08-0192","article-title":"Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation","volume":"16","author":"Alvarez","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib40","first-page":"281","article-title":"Elevated blood active ghrelin and normal total ghrelin and obestatin concentrations in uterine leiomyoma","volume":"30","author":"Markowska","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000183250","article-title":"Serum and tissue LDH levels in patients with breast\/gynaecological cancer and benign diseases","volume":"67","author":"Koukourakis","year":"2009","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib42","first-page":"437","article-title":"Staging and clinical prognostic factors for small-cell lung cancer","volume":"7","author":"Argiris","year":"2001","journal-title":"Cancer J"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0360-3016(01)01630-3","article-title":"Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer","volume":"51","author":"Brizel","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib44","doi-asserted-by":"crossref","first-page":"e33284","DOI":"10.1371\/journal.pone.0033284","article-title":"Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma","volume":"7","author":"Navarro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ygyno.2010.11.018","article-title":"Hypermethylated DAPK in serum DNA of women with uterine leiomyoma is a biomarker not restricted to cancer","volume":"121","author":"Hafner","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0090-8258(90)90165-H","article-title":"CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer","volume":"36","author":"Hunter","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib47","first-page":"590","article-title":"The value of serum CA125 assays in the diagnosis of uterine adenomyosis [in Chinese]","volume":"31","author":"Zhou","year":"1996","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jcla.20168","article-title":"Elevation of CA 19\u20139 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis","volume":"21","author":"Tsao","year":"2007","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib49","first-page":"412","article-title":"Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population","volume":"30","author":"Yilmaz","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib50","first-page":"370","article-title":"Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma","volume":"27","author":"Juang","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/172460089801300411","article-title":"CA 125 in benign gynecological conditions","volume":"13","author":"Meden","year":"1998","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib52","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jmig.2012.06.003","article-title":"Value of magnetic resonance imaging in diagnosis of adenomyosis and myomas of the uterus","volume":"19","author":"Stamatopoulos","year":"2012","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib53","first-page":"591","article-title":"Differential diagnosis between leiomyomata uteri and adenomyosis using CA 125 as a new tumor marker of ovarian carcinoma [in Japanese]","volume":"37","author":"Takahashi","year":"1985","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.humrep.a136529","article-title":"The effect of hysterectomy on serum CA 125 levels in patients with adenomyosis and uterine fibroids","volume":"2","author":"Halila","year":"1987","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.humrep.a137552","article-title":"Peripheral CA 125 levels in patients with uterine fibroids","volume":"7","author":"Bischof","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib56","first-page":"510","article-title":"Serum CA 125 concentrations in women with endometriosis or uterine fibroids treated with gonadotrophin-releasing hormone agonist analogues","volume":"83","author":"van der Spuy","year":"1993","journal-title":"S Afr Med J"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2012.07.106","article-title":"Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass","volume":"127","author":"Karlsen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib58","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib59","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib60","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1039\/C2MB05453A","article-title":"Proteomic identification of plasma biomarkers in uterine leiomyoma","volume":"8","author":"Lin","year":"2012","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib61","first-page":"1170","article-title":"Leiomyomata uteri: hormonal and molecular determinants of growth","volume":"99","author":"Blake","year":"2007","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0015-0282(16)56635-7","article-title":"Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas","volume":"61","author":"Dawood","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib63","first-page":"927","article-title":"Connection between uterine myomas and biochemical screening results in the first and second trimester of pregnancy [in Polish]","volume":"80","author":"Sieroszewski","year":"2009","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib64","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/14767058.2010.536864","article-title":"Association between uterine leiomyomas and the biochemical screening test results in the first and second trimester of pregnancy: a pilot study","volume":"24","author":"Sieroszewski","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib65","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00404-012-2404-5","article-title":"MR imaging evaluation of fibroid clearance following open myomectomy for massive\/multiple symptomatic fibroids","volume":"286","author":"Wijesekera","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1757-2215-5-11","article-title":"The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study","volume":"5","author":"Varughese","year":"2012","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib67","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0030-1251479","article-title":"Minimally invasive approach for myomectomy","volume":"28","author":"Agdi","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib68","first-page":"36","article-title":"Reassessing hysterectomy","volume":"95","author":"Stewart","year":"2012","journal-title":"Minn Med"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib69","doi-asserted-by":"crossref","unstructured":"Tirumani SH, Ojili V, Shanbhogue AK, Fasih N, Ryan JG, Reinhold C. Current concepts in the imaging of uterine sarcoma. Abdom Imaging. Published online June 15,\u00a02012.","DOI":"10.1007\/s00261-012-9919-x"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/era.09.187","article-title":"Optimal management of uterine leiomyosarcoma","volume":"10","author":"O'Cearbhaill","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib71","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bpobgyn.2011.07.002","article-title":"Clinical presentation and diagnosis of uterine sarcoma, including imaging","volume":"25","author":"Wu","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2012.10.048_bib72","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ygyno.2003.10.044","article-title":"The treatment of uterine leiomyosarcoma: results from a 10-year experience (1990\u20131999) at the Massachusetts General Hospital","volume":"92","author":"Dinh","year":"2004","journal-title":"Gynecol Oncol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028212023928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028212023928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:05:09Z","timestamp":1758009909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028212023928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0015028212023928"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.10.048","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in uterine leiomyoma","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2012.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}